Results 211 to 220 of about 180,869,100 (247)
Probiotic Intervention With Bacillus coagulans and Lactobacillus acidophilus in Small Animals Experimental Ulcerative Colitis: Insights From a Small Animal Model
Veterinary Medicine and Science, Volume 12, Issue 6, November 2026.ABSTRACT
Inflammatory bowel disease is a significant health concern not only in humans but also in companion animals and livestock, where it manifests as chronic diarrhoea, abdominal pain, and mucosal injury. Probiotics have gained increasing attention as potential therapeutic agents due to their immunomodulatory effects and ability to restore ...Fatemeh Shayesteh, Milad Shahini Shams Abadi, Leila Rouhi, Abbas Doosti, Nader Bagheri +4 morewiley +1 more sourceClinical Outcomes After Percutaneous Coronary Intervention in Patients With Cirrhosis: A Multicentre National Study
Alimentary Pharmacology &Therapeutics, Volume 64, Issue 9, Page 1219-1233, November 2026.Summary of a multicentre TriNetX study evaluating outcomes after percutaneous coronary intervention (PCI) in patients with cirrhosis. Cirrhosis was associated with higher 1‐year gastrointestinal bleeding and mortality, especially with decompensated disease.Dhir Gala, Sameer Rao, Manas Gunani, Kajol Shah, Anand V. Kulkarni, Karn Wijarnpreecha, Daniel Q. Huang, Pojsakorn Danpanichkul, Ahmed Al‐Khazraji, Kaveh Hajifathalian, Vivek Lingiah, Paul Gaglio, Nikki Duong, Christine Gerula +13 morewiley +1 more sourceA YAP–TEAD–CTCF Transcriptional Regulatory Axis Associated With the Elimination of Injured Hepatocytes From the Liver
Genes to Cells, Volume 31, Issue 6, November 2026.Injured YAP‐activated hepatocytes are eliminated from the liver. They are extruded toward the sinusoidal lumen, undergo cell death, and are phagocytosed by macrophages. Here, we performed proximity ligation assay, ATAC‐seq, RNA‐seq, and CellChat analyses.Daiki Hatakeyama, Yoshimi Okamoto‐Uchida, Misaki Kosaka, Haruka Hirose, Satoshi Kofuji, Keiko Danzaki, Yoshiki Endo, Michiko Nakagawa, Akinori Kanai, Yutaka Suzuki, Takeshi Yokoo, Shuji Terai, Teppei Shimamura, Hiroshi Nishina +13 morewiley +1 more sourceAge‐Specific Associations of Polygenic Risk Scores With Advanced Fibrosis and Histological Activity in Biopsy‐Proven MASLD
Liver International, Volume 46, Issue 11, November 2026.ABSTRACT Background and Aims
The genetic susceptibility to MASLD histological severity remains incompletely defined. We assessed the associations between recently developed genome‐wide association studies–derived polygenic risk scores (PRSs) and advanced fibrosis in MASLD.Samer Gawrieh, Jingyi Tan, Xiuqing Guo, Linus Schwantes‐An, Marco Abreu, Callie J. Zaborenko, Eduardo Vilar‐Gomez, Jeffrey B. Schwimmer, Jerome I. Rotter, Naga Chalasani +9 morewiley +1 more sourceMinimum standards for training in colorectal endoscopic mucosal resection among advanced endoscopy trainees
Endoscopy International OpenDennis Yang, Ernesto Robalino Gonzaga, Muhammad Khalid Hasan, Arvind Julius Trindade, Mark Radlinski, Rebecca A Burbridge, Jeffrey Mosko, Pushpak Taunk, Salmaan Jawaid, Mohamed O. Othman, David L Diehl, Harshit S. Khara, Quin Liu, Srinivas Gaddam, Harry Aslanian, Shailendra S Chauhan, Amrita Sethi, John Poneros, Jason Samarasena, Ali M Ahmed, Uzma D. Siddiqui, Dennis Chen, Moamen Gabr, Andrew Y. Wang, C-EMR STAT Working Group +24 moredoaj +1 more sourceMean Arterial Pressure at Admission Predicts 28-day Mortality in Patients With Severe Alcohol-Associated Hepatitis. [PDF]
Clin Transl GastroenterolVentura-Cots M, Clemente A, Alvarado-Tapias E, Ravi S, Cuyas B, Tanguy M, Poca M, Jager M, Fernández-Carrillo C, Arteel GE, Villagrasa A, Aguilar-Amorós A, Argemi J, Abraldes JG, Bosques F, Brown RS, Garcia-Taso G, Genesca J, Schanbl B, Mathurin P, Louvet A, Lucey MR, Shawcross DL, Verna E, Gawrieh S, Dasarathy S, Tu W, Kamath PS, Chalasani NP, McClain CJ, Szabo G, Tang Q, Barton B, Nagy LE, Shah VH, Sanyal AJ, Mitchell MC, Singal AK, Soriano G, Rautou PE, Bataller R. +40 moreeuropepmc +1 more sourcePharmacogenomic profiling of the efficacy of gemcitabine monotherapy in metastatic pancreatic cancer: Subgroup analysis of the GENESECT study
British Journal of Clinical Pharmacology, Volume 92, Issue 10, Page 3397-3406, October 2026.Aim
In the GENESECT study, no significant gemcitabine (GEM) metabolism‐related germline genetic polymorphisms (GPs) were identified because approximately 70% of patients received combination therapy with nab‐paclitaxel, which has metabolic pathways different from GEM.Takashi Yokokawa, Daiki Tsuji, Masahiro Hatori, Kazuyoshi Kawakami, Masahiko Nakao, Takuya Yano, Yuichiro Arakawa, Keisuke Matsuo, Yasukata Ohashi, Masato Ozaka, Naoki Sasahira, Yasuhiko Sakata, Yuki Kogure, Shinya Tamaki, Atsushi Wada, Yusuke Taki, Wataru Suzuki, Kazuo Kobayashi, Hiroshi Ishii, Kunihiko Itoh, Masakazu Yamaguchi, Kenichi Suzuki +21 morewiley +1 more source